A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib
一项针对接受克唑替尼治疗后仅出现脑转移进展的ROS1重排肺癌患者的Lorlatinib II期研究
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100347
Schneider, Jaime L; Muzikansky, Alona; Lin, Jessica J; Krueger, Elizabeth A; Lennes, Inga T; Jacobson, Joseph O; Cheng, Michael; Heist, Rebecca S; Piotrowska, Zofia; Gainor, Justin F; Shaw, Alice T; Dagogo-Jack, Ibiay